1. Biesecker, G. and Gomez, C. M. (1989) Inhibition of acute passive transfer experimental autoimmune myasthenia gravis with Fab antibody to complement C6. J. Immunol. 142, 2654–2659.
2. Christados, P. (1988) C5 influences the development of murine myasthenia gravis. J. Immunol. 140, 2589–2592.
3. Piddlesden, S., Lassmann, H., Laffafian, I., Morgan, B. P., and Linington, C. (1991) Antibody-mediated demyelination in experimental allergic encephalomyelitis is independent of complement membrane attack complex formation. Clin. Exp. Immunol. 83, 245–250.
4. Piddlesden, S. J., Storch, M. K., Hibbs, M., Freeman, A. M., Lassmann, H., and Morgan, B. P. (1994) Soluble recombinant complement receptor 1 inhibits inflammation and demyelination in antibody-mediated demyelinating experimental allergic encephalomyelitis. J. Immunol. 152, 5477–5484.
5. Rakonczay, Z. and Brimijoin, S. (1988) Monoclonal antibodies to human brain acetylcholinesterase: properties and applications. Cell Mol. Neurobiol. 8, 85–93.